RI-MUHC researchers are successful co-leaders in “100 years of insulin” funding call
Pan-Canadian team receives financing to develop a national pediatric diabetes registry
Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started
The Canadian Longitudinal Study on Aging targets brain health
Thanks to the Weston Family Foundation, the CLSA will employ MRI imaging and microbiome analyses to investigate cognitive aging
Research on dysanapsis recognized by McGill Medstar Award for Trainees
Congratulations to RI-MUHC trainee Motahareh Vameghestahbanati!
Can inhaled corticosteroids alleviate early symptoms of COVID-19?
Results from the CONTAIN study conducted at the RI-MUHC reveal that ciclesonide is no better than placebo
Regular screening for tuberculosis in Inuit communities is cost-effective
A new study from RI-MUHC researchers published in CMAJ recommends regular screening to help reduce outbreaks
Ben Geboe awarded the 2021-2022 Dr. Margaret Becklake Fellowship for his research with urban Indigenous populations
The RI-MUHC postdoc is working on a culturally safe framework for TB...
RI-MUHC researchers tackle COVID-19 vaccine hesitancy in adults and in children
Videos from projects led by Drs. Inés Colmegna and Moshe Ben-Shoshan are now available
RI-MUHC leads study of antiviral use in children hospitalized for influenza
Findings show that influenza antivirals are underutilized in Canadian pediatric hospitals, despite national clinical...
Two members of the RI-MUHC elected fellows of the Canadian Academy of Health Sciences
Congratulations to Jean Bourbeau and Togas Tulandi!